X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    development of new antibiotics

    EMA guidance supports development of new antibiotics

    Thermo Fisher Scientific Announces Collaboration with Northeastern University to Advance Biopharmaceutical Characterization and Monitoring Workflows

    Commercial Success In New Biopharmaceutical Innovation Era

    Proteros and AstraZeneca Boost Collaboration Agreement

    Conver to wp

    AbbVie and Cugene Join Forces Concerning Autoimmune Disorders and Cancer

    Drug Imagent For Therapeutic Platform

    Japan Pharma Lobby Says-Price Scheme Is Causing Drug Lag

    Charles River and Valence Discovery Announce Strategic Partnership to Provide Clients with AI-Enabled Drug Design Capabilities

    Charles River and Valo Launch Logica, an Integrated AI-Powered Drug Discovery Solution to Rapidly Deliver Optimized Preclinical Assets

    AstraZeneca announces phase IV ASCENT trial of Tudorza Pressair in patients with COPD meets primary efficacy endpoint

    AstraZeneca announces plans for new strategic R&D centre and Alexion headquarters in Cambridge, Massachusetts

    Lynparza approved in the EU for BRCA-mutated metastatic pancreatic cancer

    Major Success Factors For Clinical Development Organizations

    ArisGlobal Expands LifeSphere Clinical Portfolio with Landmark Customer Wins in APAC & Middle East

    ArisGlobal Expands LifeSphere Clinical Portfolio with Landmark Customer Wins in APAC & Middle East

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    development of new antibiotics

    EMA guidance supports development of new antibiotics

    Thermo Fisher Scientific Announces Collaboration with Northeastern University to Advance Biopharmaceutical Characterization and Monitoring Workflows

    Commercial Success In New Biopharmaceutical Innovation Era

    Proteros and AstraZeneca Boost Collaboration Agreement

    Conver to wp

    AbbVie and Cugene Join Forces Concerning Autoimmune Disorders and Cancer

    Drug Imagent For Therapeutic Platform

    Japan Pharma Lobby Says-Price Scheme Is Causing Drug Lag

    Charles River and Valence Discovery Announce Strategic Partnership to Provide Clients with AI-Enabled Drug Design Capabilities

    Charles River and Valo Launch Logica, an Integrated AI-Powered Drug Discovery Solution to Rapidly Deliver Optimized Preclinical Assets

    AstraZeneca announces phase IV ASCENT trial of Tudorza Pressair in patients with COPD meets primary efficacy endpoint

    AstraZeneca announces plans for new strategic R&D centre and Alexion headquarters in Cambridge, Massachusetts

    Lynparza approved in the EU for BRCA-mutated metastatic pancreatic cancer

    Major Success Factors For Clinical Development Organizations

    ArisGlobal Expands LifeSphere Clinical Portfolio with Landmark Customer Wins in APAC & Middle East

    ArisGlobal Expands LifeSphere Clinical Portfolio with Landmark Customer Wins in APAC & Middle East

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Europe

PersonalMed Partners with Bergen’s Elevate Provider Network to Assist Compounding Pharmacies

Yuvraj_pawp by Yuvraj_pawp
19th July 2017
in Europe, News

PersonalMed, LLC, has entered into a collaborative agreement with AmerisourceBergen’s pharmacy services administrative organization (PSAO), Elevate Provider Network, to introduce its pharmacy credentialing program. The program is available to the more than 4,500 independent pharmacies that participate in the Good Neighbor Pharmacy and Elevate Provider Network programs, and is focused on ensuring pharmacists can continue to submit claims for compounded medications to payors that are increasingly adopting credentialing and accreditation requirements.

The relationship will encourage Good Neighbor Pharmacy and Elevate Provider Network members that compound medications to earn the cCert recognition by completing PersonalMed’s compounding certification program and to take advantage of its billing and claims-management services. PersonalMed and AmerisourceBergen will officially launch the credentialing program at ThoughtSpot, Good Neighbor Pharmacy’s annual conference and trade show held July 19 – 21, 2017, at Mandalay Bay in Las Vegas.


Third-party payors – such as healthcare plan sponsors and their pharmacy benefit managers (PBMs) – are increasingly adopting credentialing and accreditation requirements to ensure that the network of pharmacies filling compounded medications meets the highest standards of quality, compliance, accreditation and transparency within their products, pricing and business practices. The goal is to ensure that Elevate members remain in network for compounded medications.


“We are excited to assist those Elevate member pharmacies that want to continue to bill compounded medications to payors,” said Ernie Rapp, president of PersonalMed. “We have seen an increasing number of payors that require credentialing for compound medications. cCert can assist Elevate members with the adherence to best practices and ensure the focus remains on quality and patient needs.”


“Many patients rely on compounded medications as the best form of therapy. and the service is an important niche for many independent pharmacies,” added Chuck Reed, group vice president of pharmacy innovation at AmerisourceBergen. “Introducing this service reaffirms our commitment to supporting the success of independent pharmacies by providing new and innovative solutions that help them accomplish their goals.”


PersonalMed is a leader in providing compounding management solutions and credentialing services; Elevate is one of the largest PSAOs in the country, helping independent pharmacies maximize profitability, improve operational effectiveness and enhance patient care. Elevate Good Neighbor Pharmacy have more than 4,500 members in its care network, and negotiates contracts with over 35 pharmacy benefit managers (PBMs) for more than 7,500 plans.


Credentialing through the joint cCert program is available to members of the Elevate Provider Network and other compounding pharmacies that meet the same participation requirements. For complete details, email contactus@personalmedrx.com or call (844) 901-7832.


About PersonalMed

PersonalMed, LLC, provides services to third-party payors to manage and process claims for compounded medications through (i) its Preferred Provider Network and (ii) its PAGO platform. The Preferred Provider Network is a high-performance network of compounding pharmacies that agree to comply with strict credentialing standards in addition to holding PCAB Accreditation, a service of the Accreditation Commission for Health Care (ACHC). PersonalMed’s credentialing focuses on accreditation, legal compliance, clinical and quality standards, ownership, training, pricing, contract compliance and business practices. PAGO is a cloud-based billing and claims management platform. For more information, visit PersonalMed’s website at www.personalmedrx.com


About AmerisourceBergen

AmerisourceBergen provides pharmaceutical products, value-driving services and business solutions that improve access to care. Tens of thousands of healthcare providers, veterinary practices and livestock producers trust us as their partner in the pharmaceutical supply chain. Global pharmaceutical manufacturers depend on us for services that drive commercial success for their products. Powered by our 19,000 associates, we are united in our responsibility to create healthier futures. AmerisourceBergen is ranked #11 on the Fortune 500, with more than $146 billion in annual revenue. The company is headquartered in Valley Forge, Pa. and has a presence in 50+ countries. Learn more at www.amerisourcebergen.com

 

Contacts
PersonalMed
Del Doherty, Pharm.D., Ph.D., MPH, 844-901-7832
Vice President of Managed Care Services
contactus@personalmedrx.com

Tags: Europe
Previous Post

Thermo Fisher Scientific Introduces Next Generation of Complementary Technologies for Forensic DNA Analysis

Next Post

Lexicon Collaborator Ipsen Receives Positive Chmp Opinion For Xermelo

Related Posts

FDA Experts Recommend Changing COVID Jab Formulation In Fall
Manufacturing

FDA Experts Recommend Changing COVID Jab Formulation In Fall

30th June 2022
Novartis to acquire The Medicines Company for USD 9.7 bn
Manufacturing

Novartis To Slash 8,000 Jobs To Save $1 Billion By 2024

30th June 2022
How Lag In African COVID-19 Jabs Slowed Its Once Rapid Pace
Manufacturing

How Lag In African COVID-19 Jabs Slowed Its Once Rapid Pace

27th June 2022
Australia Creates A Novel Stem Cell Production Technique
Manufacturing

Australia Creates A Novel Stem Cell Production Technique

27th June 2022
Novartis to acquire The Medicines Company for USD 9.7 bn
Manufacturing

Novartis Promises $250M For Tropical Illnesses, Malaria

27th June 2022
GSK commences phase III study of Benlysta and rituximab combination in systemic lupus erythematosus
Manufacturing

GSK Commits £1 Billion To Combat Infections In Poor Nations

27th June 2022
Next Post

Lexicon Collaborator Ipsen Receives Positive Chmp Opinion For Xermelo

Latest News

FDA Experts Recommend Changing COVID Jab Formulation In Fall
Manufacturing

FDA Experts Recommend Changing COVID Jab Formulation In Fall

30th June 2022
Novartis to acquire The Medicines Company for USD 9.7 bn
Manufacturing

Novartis To Slash 8,000 Jobs To Save $1 Billion By 2024

30th June 2022
How Lag In African COVID-19 Jabs Slowed Its Once Rapid Pace
Manufacturing

How Lag In African COVID-19 Jabs Slowed Its Once Rapid Pace

27th June 2022
Australia Creates A Novel Stem Cell Production Technique
Manufacturing

Australia Creates A Novel Stem Cell Production Technique

27th June 2022
Novartis to acquire The Medicines Company for USD 9.7 bn
Manufacturing

Novartis Promises $250M For Tropical Illnesses, Malaria

27th June 2022
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In